Product
JZP150
1 clinical trial
1 indication
Indication
Post-Traumatic Stress DisorderClinical trial
A Multicenter Phase 2, 12-week Double-blind, Placebo-controlled, Randomized, Parallel-group Study of JZP150 for the Treatment of Posttraumatic Stress DisorderStatus: Completed, Estimated PCD: 2023-12-05